Bausch & Lomb Corp Revenue
Bausch & Lomb Corp (BLCO) reported Revenue of $1.39 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-29
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $1.39B, a 9.08% increase year-over-year.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.24B, a 9.41% increase year-over-year.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $1.41B, a 9.77% increase year-over-year.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $1.28B, a 7.11% increase year-over-year.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for fiscal 2025 was $5.10B, a 6.47% increase from fiscal 2024.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for fiscal 2024 was $4.79B, a 15.56% increase from fiscal 2023.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for fiscal 2023 was $4.15B, a 10.03% increase from fiscal 2022.
- Bausch & Lomb Corp revenue from contract with customer, excluding assessed tax for fiscal 2022 was $3.77B, a 0.08% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.39B 10-Q · filed 2026-07-29 | $2.64B 10-Q · filed 2026-07-29 | $4.04B derived: sum of 3 quarters · filed 2026-07-29 | $5.32B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.24B 10-Q · filed 2026-04-29 | $2.65B derived: sum of 2 quarters · filed 2026-04-29 | $3.93B derived: sum of 3 quarters · filed 2026-04-29 | $5.21B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $2.69B derived: sum of 2 quarters · filed 2026-02-18 | $3.96B derived: sum of 3 quarters · filed 2026-07-29 | $5.10B 10-K · filed 2026-02-18 |
| 2025-09-30 | $1.28B 10-Q · filed 2025-10-29 | $2.56B derived: sum of 2 quarters · filed 2026-07-29 | $3.70B 10-Q · filed 2025-10-29 | $4.98B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.28B 10-Q · filed 2026-07-29 | $2.42B 10-Q · filed 2026-07-29 | $3.69B derived: sum of 3 quarters · filed 2026-07-29 | $4.89B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.14B 10-Q · filed 2026-04-29 | $2.42B derived: sum of 2 quarters · filed 2026-04-29 | $3.61B derived: sum of 3 quarters · filed 2026-04-29 | $4.83B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $1.28B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $2.48B derived: sum of 2 quarters · filed 2026-02-18 | $3.69B derived: sum of 3 quarters · filed 2026-02-18 | $4.79B 10-K · filed 2026-02-18 |
| 2024-09-30 | $1.20B 10-Q · filed 2025-10-29 | $2.41B derived: sum of 2 quarters · filed 2025-10-29 | $3.51B 10-Q · filed 2025-10-29 | $4.68B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $1.22B 10-Q · filed 2025-07-30 | $2.31B 10-Q · filed 2025-07-30 | $3.49B derived: sum of 3 quarters · filed 2026-02-18 | $4.50B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $1.10B 10-Q · filed 2025-04-30 | $2.27B derived: sum of 2 quarters · filed 2026-02-18 | $3.28B derived: sum of 3 quarters · filed 2026-02-18 | $4.31B derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $2.18B derived: sum of 2 quarters · filed 2026-02-18 | $3.21B derived: sum of 3 quarters · filed 2026-02-18 | $4.15B 10-K · filed 2026-02-18 |
| 2023-09-30 | $1.01B 10-Q · filed 2024-10-30 | $2.04B derived: sum of 2 quarters · filed 2024-10-30 | $2.97B 10-Q · filed 2024-10-30 | $3.97B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $1.03B 10-Q · filed 2024-08-01 | $1.97B 10-Q · filed 2024-08-01 | $2.96B derived: sum of 3 quarters · filed 2025-02-19 | $3.90B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $931.00M 10-Q · filed 2024-05-01 | $1.93B derived: sum of 2 quarters · filed 2025-02-19 | $2.87B derived: sum of 3 quarters · filed 2025-02-19 | $3.81B derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $996.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.94B derived: sum of 2 quarters · filed 2025-02-19 | $2.88B derived: sum of 3 quarters · filed 2025-02-19 | $3.77B 10-K · filed 2025-02-19 |
| 2022-09-30 | $942.00M 10-Q · filed 2023-11-01 | $1.88B derived: sum of 2 quarters · filed 2023-11-01 | $2.77B 10-Q · filed 2023-11-01 | $3.77B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $941.00M 10-Q · filed 2023-08-02 | $1.83B 10-Q · filed 2023-08-02 | $2.83B derived: sum of 3 quarters · filed 2024-02-21 | $3.78B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $889.00M 10-Q · filed 2023-05-03 | $1.89B derived: sum of 2 quarters · filed 2024-02-21 | $2.84B derived: sum of 3 quarters · filed 2024-02-21 | $3.77B derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.95B derived: sum of 2 quarters · filed 2024-02-21 | $2.88B derived: sum of 3 quarters · filed 2024-02-21 | $3.77B 10-K · filed 2024-02-21 |
| 2021-09-30 | $949.00M 10-Q · filed 2022-11-02 | $1.88B derived: sum of 2 quarters · filed 2022-11-02 | $2.76B 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $934.00M 10-Q · filed 2022-08-04 | $1.81B 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $881.00M 10-Q · filed 2022-06-08 | |||
| 2020-12-31 | $3.41B 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |